1.Successful surgical treatment of massive hemangioma on the face and neck.
Jae Gu PARK ; Chul Gyoo PARK ; Yoon ho LEE ; Chin Hwan KIM ; Kyung Won MIN ; Suk Wha KIM ; Sung Taek KWON
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1998;25(6):1127-1133
Hemangioma is one of the most common congenital tumors in the region of the face and neck. Although histologically benign, these facial masses are clinically malignant for their deforming and inexorable growth, especially in so-called cavernous hemangioma. Today, hemagiomas have been treated by various methods; steroids, electrocoagulation, injection of sclerosing agent, cryotherapy, radiation therapy, laser therapy, and surgical treatment, etc. The response of treatment varies with the types, surgical skills, regions of hemangioma, the age of patient, but the appropriate method of the treatment has not been yet established. In the case of massive hemangioma, which involves most part of the face and neck, we prefer surgical treatment and consistently obtain better result than other treatment modalities. Wide excision and proper reconstruction of the face helps the patient for their better life aesthetically and functionally.
Cryotherapy
;
Electrocoagulation
;
Hemangioma*
;
Hemangioma, Cavernous
;
Humans
;
Laser Therapy
;
Neck*
;
Steroids
2.A case report of Kasabach-Merritt syndrome.
Chinese Journal of Contemporary Pediatrics 2006;8(3):255-256
Female
;
Hemangioma
;
therapy
;
Humans
;
Infant, Newborn
;
Syndrome
;
Thrombocytopenia
;
therapy
3.A Case of Tracheal Hemangioma Manifested Massive Hemoptysis.
Soon Chan SO ; Kyung Kunn KWACK ; Hae Kyu PARK ; Jong Hyung KIM ; Hyun Min SHIN ; Doo Yuel LYU ; Duck Kee LEE ; Yuoon SHIN ; Seok Eun KIM ; Young Hye PARK ; Jeong Sup SONG ; Sung Hak PARK
Tuberculosis and Respiratory Diseases 1999;47(5):704-708
Hemangioma is benign tumor that represent an fail in development of the vascular system, network or retiform stage. As with hemangioma elsewhere, spontaneous regression may occur. Histologically capillary hemangioma has a diagnostic lobular arrangement of capillaries and almost all of them are located in nasal or oral mucous membranes. But, as we know, there is no report of hemangioma located in the trachea in Korea, so we report a case of tracheal hemangioma which was manifested massive hemoptysis.
Capillaries
;
Hemangioma*
;
Hemangioma, Capillary
;
Hemoptysis*
;
Korea
;
Laser Therapy
;
Mucous Membrane
;
Trachea
5.Management of head and neck hemangiomas in China.
Jia-wei ZHENG ; Guo-yu ZHOU ; Yan-an WANG ; Zhi-yuan ZHANG
Chinese Medical Journal 2008;121(11):1037-1042
6.Case of sublingual cavernous hemangioma.
Ying-Chun TENG ; Dong-Dong YU ; Mei LU
Chinese Acupuncture & Moxibustion 2014;34(1):40-40
7.A Study on the 216 Cases of Vascular Skin Lesion Treated by 585nm Flashlamp-Pumped Pulsed Dye Laser.
Hyo Hyun AHN ; Young Chul KYE ; Soo Nam KIM
Korean Journal of Dermatology 1999;37(10):1442-1449
BACKGROUND: 585nm flashlamp-pumped pulsed dye laser(FPDL) is a very effective treatment modality for vascular skin lesions with minimal risk of scarring by selective photothermolysis. OBJECTIVE: The purpose of this study was to evaluate the effectiveness of FPDL in treating various vascular lesions in Korean patients, and in order to be helpful in expecting the treatment outcome and selecting the patients. METHODS: 216 cases treated with FPDL because of vasular skin lesions- nevus flammeus, telangiectasia, hemangioma and others- were included in this study. The results of the treatment were evaluated in the point of site, color, size, surface contour of lesions and patient's age in each condition. Photographs were obtained at baseline and 4~8 week intervals postoperatively. The results were assessed by two blinded assessors and surgeon after laser surgery, based on a scale of: poor for 0~25% improvement; fair for 25~50% improvement; good for 50~75% improvement; and excellent for 75~100% improvement. RESULTS: The commonest disease for treatment was nevus flammeus, followed by telangiectasia and strawberry hemangioma. In nevus flammeus, the lesions at upper eyelids, lower eyelids, upper lip skin and lesions which were darker in color and more elevated, responded less favorably. Age and sex of patients didn't affect the outcome. In telangiectasia, the results of treatment were above good in 83% of cases. In strawberry hemangioma, the results of treatment were above good in 73% of cases. CONCLUSION: FPDL is very effective in various vascular lesions, but one must keep in mind the differences in treatment outcome according to sites, color, size, surface contour of lesions.
Cicatrix
;
Eyelids
;
Hemangioma
;
Hemangioma, Cavernous
;
Humans
;
Laser Therapy
;
Lasers, Dye*
;
Lip
;
Port-Wine Stain
;
Skin*
;
Telangiectasis
;
Treatment Outcome
8.Large Orbital Cavernous Hemangioma: A Case Report.
Sang Mo BAE ; Jae Hak JUNG ; Young Hwan KIM ; Hook SUN
Journal of the Korean Society of Plastic and Reconstructive Surgeons 2006;33(3):388-391
Hemangioma is one of the most common congenital tumors in the region of the face and neck. Although histologically benign, these facial masses are clinically malignant for their deforming and inexorable growth, especially in so-called 'cavernous hemangioma'. Carvenous hemangioma is the most common primary tumor occurring in the adult orbit. This tumor has symptoms that characteristically develop over several years with slowly progressive proptosis, eyeball deviation, hyperopia, diplopia and optic nerve compression. Today, hemangiomas are being treated by various methods; steroids, electrocoagulation, injection of sclerosing agent, cryotherapy, radiation therapy, laser therapy, and surgical treatment, etc. In principle, surgical approaches to the orbit must provide maximum safety and optimal visualization. We have experienced a case of large cavernous hemangioma in the orbit inferolaterally. The surgical treatment of tumor was achieved by the bicoronal approach combined with inferomedial and inferolateral orbitotomy. This surgical approach allows better visualization of the tumor and greater protection of essential anatomic structures. We obtained satisfactory results in terms of aesthetic and functional consideration. We present our case with a brief review of the literature related to orbital cavernous hemangioma.
Adult
;
Cryotherapy
;
Diplopia
;
Electrocoagulation
;
Exophthalmos
;
Hemangioma
;
Hemangioma, Cavernous*
;
Humans
;
Hyperopia
;
Laser Therapy
;
Neck
;
Optic Nerve
;
Orbit*
;
Steroids
9.The Treatment of Hemangioma in Lower Lip
Eun Young LEE ; Kyoung Won KIM ; Ji Yeoun LEE
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2010;32(4):373-377
hemangioma. The decision to initiate treatment is based on many factors, including size, location and risks and benefits of the proposal therapy. Systemic corticosteroids are decided to prevent the scarring and deforming. Prednisolone was given at a dose of 2 mg/kg/day for 2 weeks followed by tapering for 6 weeks for treatment. After eight weeks there was 80% reduction in the size of the lesion and the left lower lip almost completely cleared without intraoral bleeding. Furthermore, intervention by way of systemic steroids, laser therapy or surgical debulking is appropriate and safe in a select group of patients presenting with a proliferating hemangioma. This report describes a case that was sucessfully treated by systemic steroid therapy for hemangima in intraoral region.]]>
Adrenal Cortex Hormones
;
Cicatrix
;
Hemangioma
;
Hemangioma, Capillary
;
Hemorrhage
;
Humans
;
Infant
;
Laser Therapy
;
Lip
;
Male
;
Parturition
;
Prednisolone
;
Risk Assessment
;
Steroids
10.Clinical application of imiquimod for the treatment of infantile hemangiomas.
Gang MA ; Xiao-Xi LIN ; Cheng-Hong JIANG ; Hui CHEN ; Wei LI ; Xiao-Jie HU ; Yun-Bo JIN ; Da CHEN ; Xiao-Dong CHEN ; Xiao-Xiao YE
Chinese Journal of Plastic Surgery 2011;27(6):411-414
OBJECTIVETo explore the clinical application of imiquimod for the treatment of infantile hemangiomas (IH).
METHODS320 children with IH, including 250 superficial cases, 20 deep cases, and 50 mixed cases, were treated with 5% imiquimod cream every other day for 16 weeks. The clinical efficacy and side effects were evaluated at one year of age.
RESULTSThe total effective rates of the superficial, deep, and mixed IH were 61.2% (153/250), 10.0% (2/20) and 60.0% (30/50) respectively, showing no statistical difference between superficial and deep type (P = 0.874), but significant difference between superficial and mixed (P < 0.01), deep and mixed type (P < 0.01). 56.0% (28/50) of mixed IH showed proliferation of its deep lesions. Slight skin erythema and crusting were the most common side effects.
CONCLUSIONS5% imiquimod cream is effective and safe in superficial IH and superficial lesions of mixed IH with minimal skin reactions. The dysplasia of local tissue and systemic growth retardation are not found. It should be avoided to apply the cream to IH located around the cavities and skin fold. Imiquimod cream is a simple and convenient home-nursing medication. It can reduce care burden of family. Thus topical use of imiquimod can be considered as a good clinical indication for the treatment of superficial lesions of IH.
Aminoquinolines ; therapeutic use ; Female ; Hemangioma ; drug therapy ; Humans ; Infant ; Male ; Skin Neoplasms ; drug therapy ; Treatment Outcome